Joel D. Becker
CEO, President & DirectorMr. Joel D. Becker serves as CEO & Director of at NeuroPace, Inc. since July 10, 2023 and serves as its President. He had been President of Cardiac Rhythm Management & Neuromodulation at Integer Holdings Corporation since April 24, 2019 until October 07, 2022. He joined Integer Holdings in April 2019. Mr. Becker is also the leader for the Sales Force Excellence strategic imperative. Prior to joining Integer Holdings, he was the President of Viking North Ventures from October 2016 to April 2019 and served as the Chief Executive Officer of XchangeLabs LLC from August 2017 to August 2018. Prior to those positions, Mr. Becker had a nearly 20-year career with St. Jude Medical where he held a variety of different roles including President, Americas Division from July 2013 to February 2016, and President, United States Division from October 2011 to July 2013. Mr. Becker joined the St. Jude Medical Inc. in 1993 as a Senior Associate in Corporate Development. He led USD marketing efforts, including market development, product marketing, education and training, marketing communications and fellow programs. During his tenure with St. Jude Medical, he has also held numerous leadership positions in both the Cardiovascular and Atrial Fibrillation divisions. He rejoined St. Jude Medical in 2002. Mr. Becker graduated from the University of Minnesota, Carlson School of Business, where he earned an M.B.A. and Augustana College where he obtained a B.A. in Business Administration.
Positions
- Company NameNeuroPace, Inc.Stock CodeNPCEPositionCEO, President & DirectorColleagues
- FMFrank M. FischerChairman of the Board
- PFPatrick F. WilliamsChief Financial Officer
- MJMartha J. MorrellChief Medical Officer
- DSDylan St. JohnChief of Operations & Development
- SRScott R. SchaperVice President of Finance & Investor Relations
- RKRakhi KumarIndependent Director
- LMLisa M. AndradeIndependent Director
- RSRichard Scott HuennekensIndependent Director
